State of California Compliance Program Declaration
As part of our continued commitment to compliance, Gynesonics, Inc. (“Gynesonics”) has developed and implemented a Comprehensive Compliance Program consistent with the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, and with applicable state and federal laws relating to the marketing and promotion of the company’s products. The compliance program is designed in accordance with the AdvaMed Code on Interactions with Health Care Professionals, which is substantially equivalent to the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (PhRMA Code) but reflects the unique interactions between medical technology companies and health care professionals. To the best of our knowledge and based on our good faith understanding of all applicable statutory and regulatory requirements, Gynesonics is in compliance with our Comprehensive Compliance Program and with the requirements of the California Health and Safety Code § 119400-119402. Gynesonics will evaluate and update its Compliance Program, as necessary and appropriate. Gynesonics will make conforming changes to our Comprehensive Compliance Program within six months of any update or revision of the Compliance Program Guidance or AdvaMed Code.
Copies of this Declaration and a description of our Comprehensive Compliance Program may be obtained by contacting our Corporate Compliance Department at firstname.lastname@example.org or the Gynesonics corporate headquarters at 844-343-6859.
Dated: February 25, 2022